Allscripts Healthcare Solutions Given Neutral Rating at Zacks (MDRX)
Allscripts Healthcare Solutions (NASDAQ:MDRX)‘s stock had its “neutral” rating reaffirmed by Zacks in a report released on Thursday, Stock Ratings Network reports. They currently have a $15.00 price target on the stock. Zacks‘ target price would suggest a potential upside of 2.39% from the stock’s previous close.
Allscripts Healthcare Solutions (NASDAQ:MDRX) traded up 2.46% on Thursday, hitting $15.01. The stock had a trading volume of 1,801,605 shares. Allscripts Healthcare Solutions has a 1-year low of $8.85 and a 1-year high of $16.43. The stock’s 50-day moving average is $15.16 and its 200-day moving average is $14.06. The company’s market cap is $2.666 billion.
Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its earnings data on Thursday, August 8th. The company reported $0.09 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.11 by $0.02. The company had revenue of $344.80 million for the quarter, compared to the consensus estimate of $360.00 million. During the same quarter in the previous year, the company posted $0.16 earnings per share. The company’s revenue for the quarter was down 6.8% on a year-over-year basis. On average, analysts predict that Allscripts Healthcare Solutions will post $0.35 earnings per share for the current fiscal year.
A number of other analysts have also recently weighed in on MDRX. Analysts at KeyCorp initiated coverage on shares of Allscripts Healthcare Solutions (NASDAQ:MDRX) in a research note to investors on Wednesday, September 4th. They set a “hold” rating on the stock. Separately, analysts at Raymond James raised their price target on shares of Allscripts Healthcare Solutions (NASDAQ:MDRX) from $16.00 to $17.00 in a research note to investors on Tuesday, August 13th. Finally, analysts at Robert W. Baird raised their price target on shares of Allscripts Healthcare Solutions (NASDAQ:MDRX) from $16.00 to $18.00 in a research note to investors on Friday, August 9th.
One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and six have issued a buy rating to the company. Allscripts Healthcare Solutions currently has an average rating of “Hold” and a consensus target price of $15.54.
In other Allscripts Healthcare Solutions news, EVP Clifford B. Meltzer unloaded 35,000 shares of the company’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $14.56, for a total value of $509,600.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Allscripts Healthcare Solutions, Inc (NASDAQ:MDRX) is a provider of clinical, financial, connectivity and information solutions and related professional services to hospitals, physicians and post-acute organizations.
To view Zacks’ full report, visit www.zacks.com
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.